Conclusion
This case report draws attention to a potential link between germlineBRCA2 mutations and hypopharyngeal cancer. Patients with germlineBRCA2 mutations may benefit from more intensive workup when exhibiting symptoms commonly attributed to laryngopharyngitis. Successful treatment with conventional chemoradiation identifies potential increased chemo-radio-sensitivity of hypopharyngeal cancer associated with BRCA2 mutations.